Innovation in clinical trial design has become paramount to exploring ways to accelerate clinical development for CNS disorders and Immunology. Approaches that use existing datasets to reduce the size of clinical trials have come to the forefront, but the use of external control arms is limited due the inability to control bias. In this webinar, Unlearn.AI will highlight a novel technology that leverages existing data that can be applied to randomized controlled trials (RCTs) to enable smaller, more efficient clinical trials without introducing bias. RCTs that incorporate Digital Twins, or predicted placebo outcomes, can be run faster while maintaining power, reliability, and safety.

WHAT WILL BE COVERED IN THIS WEBINAR:

• Comparing external control arms to Digital Twins
• Examining how Digital Twins enable smaller, more efficient clinical trials without introducing bias
• Reviewing case studies with Digital Twins and relevant regulatory guidance

WHO SHOULD ATTEND THIS WEBINAR:

• Academia, biotech, and pharma
• CNS disorders and Immunology
• Biostatisticians
• Chief Medical Officers/Medical Directors
• Chief Innovation Officers/Head of Innovation
• Clinical Operations
• Regulatory Affairs